Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase.
Diallo
Karidia
K
McGill AIDS Centre, Lady Davis Institute-Jewish General Hospital and Department of Microbiology and Immunology, McGill University, Montreal, Québec H3T 1E2, Canada.
Götte
Matthias
M
Wainberg
M A
MA
D000818:Animals; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D054303:HIV Reverse Transcriptase / Q000235:genetics* / Q000502:physiology*; D006801:Humans; D009154:Mutation / Q000235:genetics* / Q000502:physiology*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015302:Simian Immunodeficiency Virus / Q000235:genetics
D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase